This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
stock-price-movement: Archive
Down 7.4% in 4 Weeks, Here's Why Federated Hermes (FHI) Looks Ripe for a Turnaround
by Zacks Equity Research
Federated Hermes (FHI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
FHIPositive Net Change
rsi stock-price-movement
Down 12.4% in 4 Weeks, Here's Why WisdomTree, Inc. (WT) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for WisdomTree, Inc. (WT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
WTPositive Net Change
rsi stock-price-movement
Down 16.5% in 4 Weeks, Here's Why Lindsay (LNN) Looks Ripe for a Turnaround
by Zacks Equity Research
Lindsay (LNN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
LNNPositive Net Change
rsi stock-price-movement
US Gold Corp (USAU) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
US Gold Corp (USAU) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
USAUNegative Net Change
price-performance stock-price-change stock-price-movement
Did Buffett Sell Apple and Bank of America too Early?
by Tracey Ryniec
One of the hardest things in investing is knowing when to sell a winning stock.
BACPositive Net Change AAPLNegative Net Change URIPositive Net Change HLTNegative Net Change VRTNegative Net Change
investing stock-performance stock-price-change stock-price-movement value-stocks
All You Need to Know About Royal Bank (RY) Rating Upgrade to Strong Buy
by Zacks Equity Research
Royal Bank (RY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RYPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Geely Automobile (GELHY) Upgraded to Buy: Here's Why
by Zacks Equity Research
Geely Automobile (GELHY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GELHYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
US Gold Corp (USAU) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
US Gold Corp (USAU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
USAUNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
nLight (LASR) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
nLight (LASR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LASRPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Amalgamated Financial (AMAL) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Amalgamated Financial (AMAL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AMALNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Dutch Bros (BROS) a New Strong Buy Stock
by Zacks Equity Research
Dutch Bros (BROS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
BROSPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
CBOE (CBOE) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
CBOE (CBOE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CBOEPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About IGC Pharma, Inc. (IGC) Rating Upgrade to Strong Buy
by Zacks Equity Research
IGC Pharma, Inc. (IGC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
IGCNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Ameren (AEE) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Ameren (AEE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AEENegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
LendingClub (LC) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
LendingClub (LC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Owlet (OWLT) Surges 17.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Owlet (OWLT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OWLTNegative Net Change DSGRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Colliers International (CIGI) Stock Jumps 3.8%: Will It Continue to Soar?
by Zacks Equity Research
Colliers International (CIGI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CIGINegative Net Change BEEPPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
After Golden Cross, Aaon (AAON)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AAONNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Ocular Therapeutix (OCUL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Ocular Therapeutix (OCUL), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
OCULNegative Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Las Vegas Sands (LVS) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
LVSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Here's What Could Help Investar (ISTR) Maintain Its Recent Price Strength
by Zacks Equity Research
Investar (ISTR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
ISTRNegative Net Change
price-performance stock-price-change stock-price-movement
Rigetti Computing (RGTI) Soars 9.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Rigetti Computing (RGTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RGTIPositive Net Change PHUNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Harmony Biosciences (HRMY) Moves 12.7% Higher: Will This Strength Last?
by Zacks Equity Research
Harmony Biosciences (HRMY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
HRMYNegative Net Change OCSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Home Bancorp (HBCP) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Home Bancorp (HBCP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
HBCPNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Standard Motor Products (SMP) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Standard Motor Products (SMP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SMPNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank